These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33279433)

  • 1. Comment on: "Device Outcomes in Pediatric Sacral Neuromodulation: A Single Center Series of 187 patients".
    Casal-Beloy I; García González M; García-Novoa MA; Argibay IS
    J Pediatr Urol; 2021 Feb; 17(1):73-74. PubMed ID: 33279433
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to letter to the editor Re: Device outcomes in pediatric sacral neuromodulation: A single center series of 187 patients.
    Vandersteen DR
    J Pediatr Urol; 2021 Feb; 17(1):75. PubMed ID: 33309611
    [No Abstract]   [Full Text] [Related]  

  • 3. Electrical and mechanical office-based neuromodulation.
    Kacker R; Lay A; Das A
    Urol Clin North Am; 2013 Nov; 40(4):581-9. PubMed ID: 24182977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do Patients Discontinue Overactive Bladder Medications after Sacral Neuromodulation?
    Amin K; Moskowitz D; Kobashi KC; Lee UJ; Lucioni A
    J Urol; 2019 May; 201(5):973-978. PubMed ID: 30694936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real World Performance of Sacral Neuromodulation and OnabotulinumtoxinA for Overactive Bladder: Focus on Safety and Cost.
    Chughtai B; Clemens JQ; Thomas D; Sun T; Ghomrawi H; Sedrakyan A
    J Urol; 2020 Jan; 203(1):179-184. PubMed ID: 31347949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sacral neuromodulation with an implantable pulse generator in children with lower urinary tract symptoms: 15-year experience.
    Groen LA; Hoebeke P; Loret N; Van Praet C; Van Laecke E; Ann R; Vande Walle J; Everaert K
    J Urol; 2012 Oct; 188(4):1313-7. PubMed ID: 22902022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sacral Nerve Stimulation for Pediatric Lower Urinary Tract Dysfunction: Development of a Standardized Pathway with Objective Urodynamic Outcomes.
    Schober MS; Sulkowski JP; Lu PL; Minneci PC; Deans KJ; Teich S; Alpert SA
    J Urol; 2015 Dec; 194(6):1721-6. PubMed ID: 26141849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posterior tibial nerve stimulation vs parasacral transcutaneous neuromodulation for overactive bladder in children.
    Barroso U; Viterbo W; Bittencourt J; Farias T; Lordêlo P
    J Urol; 2013 Aug; 190(2):673-7. PubMed ID: 23422257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Cost of neuromodulation therapies for overactive bladder: percutaneous tibial nerve stimulation versus sacral nerve stimulation: M. Martinson, S. MacDiarmid and E. Black J Urol 2013; 189: 210-216.
    Barnett G; Ockrim J
    J Urol; 2013 Oct; 190(4):1444-5. PubMed ID: 23886880
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sacral neuromodulation and sexuality].
    Gamé X
    Prog Urol; 2008 Mar; 18(3):167. PubMed ID: 18472069
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sacral neuromodulation: Indications and technical aspects].
    Guillot-Tantay C; Phé V
    Prog Urol; 2018 Nov; 28(14):767-771. PubMed ID: 30174170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: is on-demand sacral neuromodulation in patients with OAB syndrome a feasible therapy regime?
    Wein AJ
    J Urol; 2013 Feb; 189(2):610-1. PubMed ID: 23312179
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of bilateral sacral nerve stimulation in patients with loss of unilateral treatment efficacy.
    Marcelissen TA; Leong RK; Serroyen J; van Kerrebroeck PE; De Wachter SG
    J Urol; 2011 Mar; 185(3):976-80. PubMed ID: 21247601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onset of Action of Sacral Neuromodulation in Lower Urinary Tract Dysfunction-What is the Optimal Duration of Test Stimulation?
    Jairam R; Drossaerts J; Marcelissen T; van Koeveringe G; van Kerrebroeck P
    J Urol; 2018 Jun; 199(6):1584-1590. PubMed ID: 29291416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sacral neuromodulation - when and for who.
    Mass-Lindenbaum M; Calderón-Pollak D; Goldman HB; Pizarro-Berdichevsky J
    Int Braz J Urol; 2021; 47(3):647-656. PubMed ID: 33621015
    [No Abstract]   [Full Text] [Related]  

  • 16. Pyriformis muscle hematoma after percutaneous nerve sacral neuromodulation trial.
    Dueñas-Garcia OF; Green N; Shapiro RE
    Int Urogynecol J; 2022 Oct; 33(10):2911-2912. PubMed ID: 35394139
    [No Abstract]   [Full Text] [Related]  

  • 17. Real-Time Changes in Brain Activity during Sacral Neuromodulation for Overactive Bladder.
    Gill BC; Pizarro-Berdichevsky J; Bhattacharyya PK; Brink TS; Marks BK; Quirouet A; Vasavada SP; Jones SE; Goldman HB
    J Urol; 2017 Dec; 198(6):1379-1385. PubMed ID: 28645869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sacral neuromodulation for treating the symptoms of overactive bladder syndrome and non-obstructive urinary retention: >10 years of clinical experience.
    Chartier-Kastler E
    BJU Int; 2008 Feb; 101(4):417-23. PubMed ID: 18070181
    [No Abstract]   [Full Text] [Related]  

  • 19. [Neuromodulation as a treatment for overactive bladder syndrome].
    Smits MA; Marcelissen TA; van Kerrebroeck PE; de Wachter SG
    Ned Tijdschr Geneeskd; 2012; 156(33):A4135. PubMed ID: 22894803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost of neuromodulation therapies for overactive bladder: percutaneous tibial nerve stimulation versus sacral nerve stimulation.
    Martinson M; MacDiarmid S; Black E
    J Urol; 2013 Jan; 189(1):210-6. PubMed ID: 23174264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.